The inhibition of VEGF or its receptor signaling system has been used to treat several types of cancer, such as colorectal cancer, renal cell carcinoma, and non-small-cell lung carcinoma [31]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.